High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users.
BACKGROUND
Little is known about behaviors linked to gamma hydroxybutyrate (GHB) morbidity.


METHODS
We surveyed 131 GHB users, using logistic regression to test the associations between the high risk behaviors and hospital treatment for GHB (26 [20%] of subjects).


RESULTS
Increased risk of GHB hospital treatment was associated with: co-ingestion of ethanol (OR 5.2; 95% CI 1.7-16), driving under the influence of GHB (OR 3.2; 95%, CI 1.3-7.8),use of GHB to treat withdrawal symptoms (OR 2.9; 95% CI 1.1-7.9), and co-ingestion of ketamine (OR 2.7; 95% CI 1.1-6.7).


CONCLUSIONS
Targeted prevention activities could focus on selected high-risk behaviors.
Kim
Susan Y
SY
California Poison Control System, Department of Clinical Pharmacy, University of California, San Francisco, CA 94143-1369, USA. susank@calpoison.org
Anderson
Ilene B
IB
Dyer
Jo Ellen
JE
Barker
Judith C
JC
Blanc
Paul D
PD
D000328:Adult; D000430:Alcohol Withdrawal Delirium / Q000453:epidemiology; D019973:Alcohol-Related Disorders / Q000453:epidemiology / Q000523:psychology; D000700:Analgesics; D001334:Automobile Driving / Q000523:psychology / Q000706:statistics & numerical data; D015897:Comorbidity; D005260:Female; D006306:Health Surveys; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D013287:Illicit Drugs / Q000633:toxicity*; D007649:Ketamine; D008297:Male; D012044:Regression Analysis; D012309:Risk-Taking; D012978:Sodium Oxybate / Q000633:toxicity*; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000523:psychology; D014481:United States
D000700:Analgesics; D013287:Illicit Drugs; D007649:Ketamine; D012978:Sodium Oxybate